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Introduction
A pivotal step in apoptosis is activation of Bax and Bak. It leads 
to mitochondrial outer membrane permeabilization (MOMP) 
and the release to the cytosol of apoptogenic molecules such as 
cytochrome c, which provoke the proteolytic caspase cascade 
that dismantles the cell (Adams and Cory, 2007). Prosurvival 
members of the Bcl-2 family (Bcl-2, Bcl-xL, Bcl-w, Mcl-1, and 
A1) prevent Bax/Bak activation and thereby preclude MOMP 
and apoptosis. The BH3-only proteins (e.g., Bim, Bid, Puma, 
Bad, and Noxa) promote cell death, but how they do so remains 
vigorously debated (Adams and Cory, 2007; Chipuk and Green, 
2008). BH3-only proteins bind tightly and neutralize distinct 
subsets of prosurvival relatives (Fig. 1 A; Chen et al., 2005;   
Kuwana et al., 2005; Certo et al., 2006), and the indirect activa-
tion model suggests that engaging all of them is necessary and 
seemingly sufficient to activate Bax and Bak (Chen et al., 2005; 
Willis et al., 2005, 2007). In this model, the prosurvival Bcl-2 
family members hold subpopulations of Bax and Bak molecules 
in check until BH3-only proteins free them. However, in cell-
free studies, BH3 peptides from Bim or Bid and the active form 
of Bid (truncated Bid [tBid]) can activate Bax or Bak directly 
and cause MOMP (Letai et al., 2002; Kuwana et al., 2005; Certo 
et al., 2006; Walensky et al., 2006; Gavathiotis et al., 2008; 
Lovell et al., 2008). The direct activation model posits that this 
interaction is critical; it suggests that the other BH3-only pro-
teins, termed “sensitizers” (e.g., Bad and Noxa), function sim-
ply by binding the prosurvival proteins to free any sequestered 
Bim or tBid. Although the Puma BH3 has also been proposed to 
bind and activate Bax (Cartron et al., 2004; Kim et al., 2006; 
Gallenne et al., 2009), other findings argue against that (Kuwana 
et al., 2005; Certo et al., 2006; Willis et al., 2007; Chipuk et al., 
2008; Jabbour et al., 2009).
As the central issue of how the BH3-only proteins trigger 
apoptosis has not been resolved by the many experiments with 
overexpressed proteins in cell lines or the use of BH3 peptides 
in cell-free systems, we have devised a genetic approach to in-
vestigate this important question in vivo. We have focused on 
the Bim locus because, unlike Bid, Puma, Bad, or Noxa (Strasser, 
2005),  its  disruption  markedly  increases  hematopoietic  cell 
numbers (Bouillet et al., 1999). Bim loss also prevents the fatal 
polycystic  kidney  disease  (PKD)  and  other  degenerative  dis 
orders provoked by the abnormal cell attrition in the absence of 
  P
roteins of the Bcl-2 family are critical regulators of 
apoptosis, but how its BH3-only members activate 
the essential effectors Bax and Bak remains contro-
versial. The indirect activation model suggests that they 
simply must neutralize all of the prosurvival Bcl-2 family 
members, whereas the direct activation model proposes 
that Bim and Bid must activate Bax and Bak directly. As 
numerous in vitro studies have not resolved this issue, 
we have investigated Bim’s activity in vivo by a genetic 
approach. Because the BH3 domain determines binding 
specificity for Bcl-2 relatives, we generated mice having 
the Bim BH3 domain replaced by that of Bad, Noxa, or 
Puma. The mutants bound the expected subsets of pro-
survival relatives but lost interaction with Bax. Analysis of the 
mice showed that Bim’s proapoptotic activity is not solely 
caused by its ability to engage its prosurvival relatives or 
solely to its binding to Bax. Thus, initiation of apoptosis in 
vivo appears to require features of both models.
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Mcl-1 (Fig. 1 C). The Bim
Bad and Bim
Puma peptides bound at 
least as tightly as the WT Bim peptide to Bcl-xL, as did the   
Bim
Puma peptide to Mcl-1. The Bim
Noxa peptide bound Mcl-1 
approximately fivefold less tightly than its WT Bim counter-
part, which is in keeping with the lower affinity of Noxa than 
Bim for Mcl-1 (Chen et al., 2005). Similar tests of the binding 
of the peptides to Bax (Fig. 1 D) showed that WT Bim peptide 
bound full-length Bax, albeit much more weakly (IC50 =   
3.1 µM) than the low nanomolar binding to its prosurvival rela-
tives, but neither the Bim
Bad, Bim
Noxa, nor Bim
Puma peptide bound 
Bax detectably (IC50 > 20 µM; Fig. 1 D).
Mice  homozygous  for  each  mutation  (designated  Bim
B/B, 
Bim
N/N, and Bim
P/P) were outwardly indistinguishable from WT 
littermates. The knockin mutations do not alter the exon structure, 
splicing sites, or any Bim motif (e.g., phosphorylation or ubiqui-
tination sites) implicated in regulating its level or activity (Fig. 2 A). 
Accordingly, Western blots of thymocyte lysates revealed that the 
Bim
Bad and Bim
Puma mice had WT Bim levels, and those in Bim
Noxa 
mice appeared only slightly lower (Fig. 2 B). The levels of other 
family members (Bcl-2, Bcl-xL, Mcl-1, and Bax) were unaffected 
(Fig. 2 B). As expected, ionomycin increased Bim expression com-
parably in both the mutant and WT thymocytes (Fig. 2 C).
We verified that the mutant Bim proteins had the expected 
binding profiles (Fig. 1 A) by coimmunoprecipitation from 
thymocyte lysates. Indeed, Bim
Bad bound Bcl-2 and Bcl-xL but not 
Mcl-1,  and  Bim
Noxa  bound  Mcl-1  but  not  Bcl-2  or  Bcl-xL, 
whereas Bim
Puma, like WT Bim, bound all of these prosurvival 
proteins (Fig. 2 C). Because the only mouse Bim isoform that 
Bcl-2 (Bouillet et al., 2001). Bim is an unstructured polypeptide 
(Hinds et al., 2007), and its binding specificity, like that of other 
BH3-only proteins, appears to be defined entirely by its BH3 
domain (Chen et al., 2005). We have altered its specificity by 
engineering knockin mouse strains having its BH3 domain   
replaced by that of Bad (Bim
Bad), Noxa (Bim
Noxa), or Puma   
(Bim
Puma). The Bim BH3 can bind to all of its prosurvival rela-
tives and weakly to Bax; the Puma BH3 also engages all of the 
prosurvival proteins, whereas the Bad and Noxa BH3 bind only 
subsets of them and not Bax (Fig. 1 A).
These mice allow tests within the physiological setting of 
whether Bim’s proapoptotic function relies upon engaging Bax 
or all of its prosurvival relatives. Surprisingly, the observed 
phenotypes of the Bim BH3 mutant mice in both the wild-type 
(WT) and sensitized Bcl-2–deficient background do not en-
tirely fit with either model and suggest that aspects of each 
must hold to fully account for Bim’s ability to initiate pro-
grammed cell death.
Results and discussion
Generation of mice with altered  
Bim specificities
Fig. 1 B depicts the Bim mutations generated. Because the bind-
ing affinity of a BH3-only protein determines its proapoptotic 
potential (Chen et al., 2005; Kuwana et al., 2005; Certo et al., 
2006; Lee et al., 2008), we determined the affinities of 26-mer 
peptides  spanning  the  mutant  BH3  domains  for  Bcl-xL  and   
Figure 1.  BH3 replacements in Bim alter its binding profile. (A) Interactions between Bcl-2 family members show the rationale of our experiments. Bad 
binds Bcl-2, Bcl-xL, and Bcl-w, whereas Noxa binds only Mcl-1 and A1. Bim and Puma bind all of their prosurvival relatives, but Bim (the BimS isoform) binds 
Bax, whereas Puma does not. (B) Amino acids 140–161 of mouse BimEL (red) were replaced by the BH3 sequences of mouse Bad, NoxaA, or Puma. Boxed 
sequences indicate the 26-mer peptides used to measure the affinities of the mutant BH3 peptides for mouse Bcl-xL, Mcl-1, and Bax. (C) Nanomolar affini-
ties of the BH3 peptides for GST–Bcl-xL and GST–Mcl-1 as measured on an S51 biosensor. (D) Tests for binding of the same peptides to Bax. The dashed 
line corresponds to the method used to determine the IC50 value. Starting from the left side, 50% binding of Bim to Bax occurs when a concentration of   
3.1 µM of peptide is present in the system. The horizontal dashed line is for the 50%, the place where it intersects with the curve determines the position 
of the vertical line, and the reading is made on the peptide concentration scale.357 BIM DOES MORE THAN INHIBIT PROSURVIVAL RELATIVES • Mérino et al.
BH3 replacement mutants retain all, some or none of Bim’s pro-
apoptotic activity, we compared their WBC numbers and spleen 
weight and those of mice bred to bear both a Bim
Bad and a 
Bim
Noxa allele (Bim
B/N animals) with the levels in WT, Bim
+/, 
and Bim
/ mice (Fig. 3 A). For all genotypes, WBC numbers 
mirrored spleen weight, as expected. Fig. 3 B compares the 
observed phenotypes with those predicted by the indirect and 
direct activation models.
Consistent with the inability of Bim
Bad or Bim
Noxa to 
bind certain prosurvival relatives (Figs. 1 and 2), each had   
reduced proapoptotic function: both Bim
B/B and Bim
N/N mice 
had significantly more WBCs and greater spleen weight than 
WT mice (Fig. 3 A). Thus, Bim
Bad and Bim
Noxa are hypo-
morphs, as expected from the indirect activation model (Fig. 3 B). 
Comparison with the Bim
/ mice clearly shows that each   
retained substantial proapoptotic activity, indeed more than 
half of the WT Bim activity (Fig. 3 A). As neither Bim
Bad nor 
Bim
Noxa binds Bax (Figs. 1 D and 2 D), this conflicts with the 
binds Bax detectably (in Triton X-100–containing buffers) is 
BimS (Willis et al., 2007), the rarest of the three main Bim iso-
forms in all tissues (O’Connor et al., 1998), we overexpressed 
the L and S isoforms of WT Bim and each Bim BH3 mutant in 
COS cells and tested their binding to endogenous Bax. As ex-
pected, WT BimS but not WT BimL bound some Bax, but nei-
ther form of Bim
Bad, Bim
Noxa, or Bim
Puma bound detectable Bax 
(Fig. 2 D), which is in accord with the BH3 peptide–binding 
data (Fig. 1 D). Thus, none of the Bim mutants should have 
direct activator function for Bax. No binding of any Bim isoform 
to Bak has been detected (Willis et al., 2007).
Engaging all prosurvival relatives is 
necessary but not sufficient for full  
Bim proapoptotic function
As Bim plays major roles in hemopoietic homeostasis, Bim-
null mice accumulate excess white blood cells (WBCs) and 
splenocytes (Bouillet et al., 1999). To determine whether the 
Figure 2.  BH3 replacements in Bim change its binding profile. (A) Knockin strategy for the BH3 replacements (not to scale). Note that the introduced 
sequences do not overlap the splice sites. (B) Normal expression of the Bim mutant proteins and Bcl-2 family members in the thymi of 6–8-wk-old knockin 
animals. Triton X-100 lysates of 4 × 10
6 cells were loaded per lane. The Western blots show samples from two animals per genotype. Hsp70 provided 
a loading control. (C) Immunoprecipitations (IPs) from thymocyte extracts of the indicated genotypes reveal the binding of WT Bim and the mutants to 
prosurvival relatives. (D) Test for binding of WT Bim and the mutants to Bax. HA-tagged BimL (L) and BimS (S) isoforms of each protein were overexpressed 
in COS-7 cells, lysates were prepared in buffer containing Triton X-100, which promotes heterodimerization, and association with endogenous Bax was 
tested using an anti-HA antibody–coupled affinity resin. Only WT BimS showed significant binding to Bax. (C and D) The asterisks indicate nonspecific 
bands caused by the secondary antibody. (B–D) Molecular mass is shown in kilodaltons.JCB • VOLUME 186 • NUMBER 3 • 2009   358
We reasoned that if antagonizing prosurvival Bcl-2 family 
members was the sole function of Bim, combining Bim
Bad and 
Bim
Noxa should reconstitute its full function (Fig. 1 A), and thus, 
the Bim
B/N mice might have a WT phenotype (Fig. 3 B). How-
ever, they also presented with significantly greater WBC num-
bers and spleen weights (P < 0.0001) than WT mice (Fig. 3 A), 
which is in conflict with indirect activation. A caveat is that 
these mice possess only a single allele of each Bim BH3 mu-
tant; thus, any cells relying entirely on Bcl-2/Bcl-xL/Bcl-w or 
entirely on Mcl-1/A1 for their survival would have an advan-
tage because they would behave as if they had only half a dose 
of Bim. In any case, the retention of substantial proapoptotic 
function by Bim mutants that do not bind Bax argues that direct 
activation of Bax cannot be the sole essential proapoptotic func-
tion of Bim (Fig. 3 B).
Unlike the long-term effects on cell death in vivo in   
Fig. 3 A, in vitro survival assays with several cytotoxic stim-
uli on sorted thymocyte and B cell populations from mice of 
all of the genotypes (illustrated for CD4
+8
+ thymocytes in 
Fig. S1) revealed no significant differences between the death 
rates of Bim
B/B, Bim
N/N, Bim
B/N, Bim
P/P, and WT cells. The 
comparable killing by mutant and WT Bim with certain stim-
uli in ex vivo assays (Fig. S1) suggests that distinguishing 
subtle differences in their apoptotic potential requires analy-
sis of long-term effects in vivo. The discrepancy between the 
in vivo and in vitro results probably reflects both the substan-
tial activity of the mutants and the difficulty of fully replicat-
ing in vivo stresses in vitro.
The Bim mutants ameliorate or prevent  
the PKD and lymphopenia provoked by  
Bcl-2 deficiency
In the absence of Bcl-2, Bim drives the attrition of several tis-
sues  (Bouillet  et  al.,  2001).  On  the  C57BL/6  background,   
Bcl-2–deficient mice are runty (Fig. 4 A), profoundly lympho-
penic, and usually die by 6–7 wk of age from the renal failure 
induced by PKD, but all of these degenerative disorders are pre-
vented by loss of Bim, and even loss of a single Bim allele pre-
cludes  the  PKD  and  renders  the  mice  as  healthy  as WT  or 
Bcl-2
/ Bim
/  animals (Bouillet et al., 2001).
Because Bim
Bad, Bim
Noxa, and Bim
Puma all behaved as hypo-
morphs (Fig. 3), we reasoned that they might ameliorate or 
even prevent some of the disorders in Bcl-2–deficient mice. 
Indeed, breeding Bcl-2–null animals expressing each mutant 
revealed that no Bcl-2
/Bim
B/B or Bcl-2
/Bim
N/N mice developed 
PKD. These animals grew normally (Fig. 4 D) and had normal 
kidney histology (Fig. S2). They differed from Bcl-2–proficient 
littermates only by turning gray at 5–7 wk of age, as expected if 
some Bim function remains in melanocytes (Bouillet et al., 2001). 
Thus, Bim
Bad and Bim
Noxa also retained partial Bim function in 
a nonhemopoietic cell type, which is in accord with indirect but 
not direct activation (Fig. 3 B).
Remarkably, although the growth of Bcl-2
/Bim
P/P mice 
was retarded (Fig. 4, A and D), most of these animals (n = 24) 
became  healthy  adults. These  mice  were  smaller  than WT 
mice, and their kidneys showed mild signs of PKD (Fig. 4 B 
and Fig. S2 A), but it progressed slowly, and they could live up 
direct activation model (Fig. 3 B). Overall, these results suggest 
that neutralization of any of the prosurvival proteins increases 
the odds that many cells will undergo apoptosis. Surprisingly, 
Bim
Puma also proved to be a hypomorph because the Bim
P/P mice 
had significant albeit smaller increases in their WBCs (P = 0.02; 
n = 39) and spleen weight (P = 0.019; n = 13) over WT mice 
(Fig. 3 A). Thus, although Bim
Puma and WT Bim bind all of the 
prosurvival members with comparable high affinity (Figs. 1 C 
and 2 C), Bim
Puma is somewhat less potent than WT Bim, a find-
ing which is discordant with both models (Fig. 3 B).
Figure 3.  BH3 replacements in Bim restrict its function. (A) WBC num-
bers in at least 16 mice of each genotype were determined on an ADVIA 
blood analyzer. Spleens of at least eight mice per genotype were weighed. 
Means  ±  SEM  are  shown,  and  the  significance  of  differences  from   
WT cells was determined by two-tailed t tests (*, P < 0.05; ***, P < 0.001).   
(B) The phenotypes of the BH3 substitution mutants predicted by the indirect 
and direct activation models and the observed phenotype. The prediction 
by the direct activation model for Bim
Puma depends on whether Puma is an 
activator, which remains in dispute (see Introduction).359 BIM DOES MORE THAN INHIBIT PROSURVIVAL RELATIVES • Mérino et al.
However, splenic structure was normal in Bcl-2
/Bim
B/B,   
Bcl-2
/Bim
N/N,  and  Bcl-2
/Bim
B/N  mice  and,  remarkably, 
even in Bcl-2
/Bim
P/P animals (Fig. 4 C and Fig. S3). As in 
the Bcl-2–proficient animals (Fig. 2), spleen weights and WBC 
numbers varied in parallel with genotype, and all of the mu-
tants behaved as hypomorphic Bim alleles (Fig. 4 E). Also, the   
Bcl-2
/Bim
B/N  spleens  were  much  heavier  than  those  in   
to 300 d, whereas all 35–40-d-old Bcl-2
/Bim
+/+ mice exhib-
ited large kidney cysts (Fig. 4 B) and died by 50 d. The less   
severe PKD in Bcl-2
/Bim
P/P mice than in Bcl-2
/Bim
+/+ mice 
confirms that Bim
Puma is less potent than WT Bim in these cells.
Bcl-2
/Bim
+/+ mice have very small spleens (5–10 mg 
vs. 60–100 mg in WT) with very few lymphoid follicles (white 
pulp) but many apoptotic cells (Fig. 4, C and E; and Fig. S2). 
Figure 4.  BH3 mutations in Bim ameliorate the degenerative disorders of Bcl-2–deficient mice. (A) A 40-d-old Bcl-2
/Bim
+/+ mouse and its WT littermate 
are shown above a 120-d-old Bcl-2
/Bim
P/P mouse and a WT mouse of that age. (B) Kidneys of Bcl-2
/Bim
P/P mice show only mild signs of PKD compared 
with Bcl-2
/Bim
+/+ kidneys. (C) Normal spleen structure in Bcl-2
/Bim
P/P mice versus the atrophied Bcl-2
/Bim
+/+ spleen. (D) Weights of WT and 
Bcl-2–null mice at 40 and 80 d showing that the Bcl-2–null Bim
Bad and Bim
Noxa animals grow normally, whereas growth of the Bim
Puma mice is retarded 
(P < 0.0001) but much less so than the Bcl-2
/Bim
+/+ animals, which have all died by 80 d (cross). (E) Blood composition for at least 10 mice per genotype 
was analyzed on an ADVIA blood analyzer, except for the Bcl-2
/Bim
+/+ animals (n = 4). Spleens from at least eight mice per genotype were weighed, 
except for the Bcl-2
/Bim
+/+ animals (n = 5). Means ± SEM and the significance of differences (by two-tailed t test) from the values in Bcl-2
/Bim
+/+ animals   
(*, P < 0.05; ***, P < 0.001) are shown. Bars, 1 mm.JCB • VOLUME 186 • NUMBER 3 • 2009   360
of them must increase the probability that a cell will undergo 
apoptosis (Fig. 5 B). Notably, although neither the Bad nor the 
Noxa BH3 binds to Bax (Figs. 1 D and 2 D), both Bim
Bad and 
Bim
Noxa  retained  substantial  proapoptotic  activity,  at  least  in   
hematopoietic cells and melanocytes, indicating that engage-
ment of Bax is not essential for Bim function (Fig. 3 B).
Because Bim
Puma and the combination of Bim
Bad plus   
Bim
Noxa can engage all of the prosurvival Bcl-2 family members 
(Figs. 1 and 5 C), the indirect activation model predicts that both 
should have full WT Bim function (Fig. 3 B). Instead, leukocytes 
accumulated abnormally in both Bim
P/P and Bim
B/N mice (Fig. 3 A). 
The far greater health of Bcl-2
/Bim
P/P than Bcl-2
/Bim
+/+ 
mice (Fig. 4) also clearly shows that Bim
Puma is less potent than 
WT Bim. Thus, binding to prosurvival Bcl-2 family members 
does not fully account for Bim’s proapoptotic activity (Fig. 5 D). 
This conclusion could only be reached by studying the long-term 
effects of altering Bim’s specificity in a physiological context.
The most plausible additional Bim BH3 function is (tran-
sient) engagement of Bax (Fig. 5 D; Letai et al., 2002; Kuwana 
et al., 2005). The WT but not the mutant Bim BH3 peptide 
bound measurably to Bax (Fig. 1 D), and full-length BimS but 
not BimL coimmunoprecipitated with Bax (Fig. 2 D). Because 
WT BimS but neither the S nor L isoform of Bim
Bad, Bim
Noxa, or 
Bim
Puma bound Bax detectably (Fig. 2 D), engagement of Bax 
by BimS might account for the additional Bim function (Weber 
et al., 2007). Alternatively, the more abundant BimL and BimEL 
might also do so but be more quickly displaced by the resulting 
Bax conformational changes so that those complexes cannot 
readily be detected. This conclusion is in accord with recent evi-
dence that a stabilized Bim BH3 peptide can interact weakly with 
Bax and provoke its activation and oligomerization (Gavathiotis 
et al., 2008).
Thus, our results suggest that the ability of Bim to engage 
its prosurvival relatives accounts for much of its proapoptotic 
Bcl-2
/Bim
+/+ mice (P < 0.0001) or even Bcl-2
/Bim
+/ ani-
mals (P < 0.0001), and WBCs were approximately sixfold more 
abundant in Bcl-2
/Bim
B/N than in Bcl-2
/Bim
+/+ mice (P = 
0.0003). The greater potency of WT Bim or even of a single 
WT Bim allele than the combination of Bim
Bad plus Bim
Noxa 
conflicts with the indirect activation model (Fig. 3 B).
Similarly, the spleens of Bcl-2
/Bim
P/P mice were heavier 
than the Bcl-2
/Bim
+/+ spleens (Fig. 4 E) and displayed less 
apoptosis (Fig. S3). The Bcl-2
/Bim
P/P mice also had more 
WBCs than the Bcl-2
/Bim
+/+ mice (P = 0.018) but decidedly 
fewer WBCs and lower spleen weights than the Bcl-2
/Bim
B/B 
or Bcl-2
/Bim
N/N animals (Fig. 4 E). Thus, Bim
Puma again is the 
mutant most similar to WT Bim, which is in accord with its 
ability to engage all of the prosurvival proteins (Fig. 1 A), em-
phasizing this as a critical part of Bim function. Nevertheless, 
Bim
Puma is less potent than WT Bim despite binding to the pro-
survival proteins with similar affinity (Fig. 1 C). Thus, WT Bim 
has a function beyond engaging all of its prosurvival relatives.
Aspects of both indirect and direct 
activation appear to contribute to 
programmed cell death in vivo
Our interpretation of these findings on the role of Bim in pro-
grammed  cell  death  within  the  intact  animal  is  depicted  in   
Fig. 5. They show first that restricting Bim’s binding spectrum 
for Bcl-2–like prosurvival proteins indeed limits its proapoptotic 
potential, which is consistent with the indirect model for Bax/
Bak activation (Chen et al., 2005; Willis et al., 2007). Thus, both 
Bim
Bad and Bim
Noxa, which each bind only a subset of the prosur-
vival proteins (Figs. 1 and 4 B), were less potent than WT Bim, 
as shown both by elevated hematopoietic cell numbers (Figs. 3 
and 4 E) and their prevention of the PKD and lymphopenia pro-
voked by Bcl-2 loss (Fig. 4 and Fig. S2). As neither Bim
Bad nor 
Bim
Noxa binds all of the prosurvival proteins, inactivation of any 
Figure  5.  Model  for  the  initiation  of  apoptosis  by 
Bim. (A) In the absence of Bim, Bax is kept in check 
by both subsets of its prosurvival relatives (“Bcl” repre-
sents Bcl-2, Bcl-xL, and Bcl-w; “Mcl” represents Mcl-1 
and A1; Willis et al., 2007). (B) In cells expressing 
Bim
Bad, the Bcl subset is neutralized, but the Mcl subset 
still partially restrains Bax and limits its induction of 
apoptosis. Conversely, in Bim
Noxa mice, Bax is partly 
restrained by the Bcl proteins. (C) In mice expressing 
Bim
Puma, all of the prosurvival proteins are neutralized, 
allowing the unrestrained Bax to induce very substan-
tial apoptosis. (D) Unlike the three Bim BH3 mutants, 
WT Bim is proposed to also bind transiently to Bax, 
giving maximal activity.361 BIM DOES MORE THAN INHIBIT PROSURVIVAL RELATIVES • Mérino et al.
Immunofluorescent staining, FACS analysis, cell sorting, tissue culture, 
and cell survival assays
Leukocyte subpopulations were identified and sorted as described previ-
ously (Bouillet et al., 1999). Cells were incubated in medium alone (no 
treatment; i.e., cytokine deprivation) or treated with 1 µg/ml ionomycin, 
10 ng/ml PMA, or 1 µM ABT-737 (Oltersdorf et al., 2005). Cell survival 
was quantified daily by staining with 2 µg/ml propidium iodide and 
FACS analysis.
Online supplemental material
Fig. S1 shows the survival of CD4
+8
+ thymocytes from Bim
/, Bim
+/,   
Bim
B/B, Bim
N/N, Bim
P/P, Bim
B/N, and WT mice in vitro after treatment with 
different apoptotic stimuli. Fig. S2 shows that BH3-replacement mutations 
prevent the development of PKD and spleen atrophy in Bcl-2–deficient mice.   
Fig. S3 shows that BH3-replacement mutations preclude the excessive apop-
tosis in the spleen of Bcl-2–deficient mice. Online supplemental material is 
available at http://www.jcb.org/cgi/content/full/jcb.200905153/DC1.
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